Status
Conditions
Treatments
About
Prostate cancer is one of the most common malignancies in the male genitourinary system, and it is also the cancer with the fastest-growing incidence and mortality rates among men in China. Although prostate cancer screening can significantly reduce mortality, China has not yet established a well-developed screening system, which is one of the reasons why its mortality rate remains notably higher than that of Western countries. The primary objective of this project is to establish an efficient screening-diagnosis-treatment pathway, beginning with screening in community hospitals, followed by definitive diagnosis in secondary hospitals, and finally treatment in tertiary hospitals. Additionally, the project aims to achieve multi-institutional and multi-terminal sharing of disease information as well as dynamic monitoring and follow-up. The feasibility and effectiveness of this model will be validated through statistical analysis of the data.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Life expectancy > 10 years and ECOG performance status of 0-2;
Permanent residents of Beijing who are willing to cooperate with researchers in the screening process, complete required tests and questionnaires, and participate in subsequent follow-up;
Support for the research project and provision of signed informed consent.
Exclusion criteria
Loading...
Central trial contact
Zejin Ou
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal